期刊文献+

磺胺二甲嘧啶生理药动学模型种间类推的应用 被引量:2

The Interspecies Extrapolation of Sulfamethazine Physiologically Based Pharmacokinetic Model
下载PDF
导出
摘要 本研究应用磺胺二甲嘧啶在猪的生理药动学模型来预测其在绵羊体内的动力学过程。利用文献中已经建立的猪的生理模型,采用动物种间类推原理,将模型外推至绵羊,模拟磺胺二甲嘧啶在绵羊体内的血药和组织浓度,并估算可食性组织残留休药期。结果模拟休药期和文献休药期基本趋于一致,表明生理药动学模型种间类推是可行的。 The objective of this paper was to predict kinetic process of Sulfamethazine in sheep on the basis of the physiologically based pharmacokinetic model of Sulfamethazine in pig.The PBPK model in pig was extrapolated to sheep based on the interspecies scaling theory,to simulate the plasma and tissues concentration of Sulfamethazine and estimate residue withdrawal times in edible tissues in sheep.The results showed that the simulated withdrawal times was according to the reported withdrawal times.The interspecies extrapolation of PBPK model was feasible.
出处 《中国畜牧兽医》 CAS 北大核心 2010年第3期194-197,共4页 China Animal Husbandry & Veterinary Medicine
关键词 磺胺二甲嘧啶 生理药动学模型 绵羊 Sulfamethazine physiologically based pharmacokinetic model sheep
  • 相关文献

参考文献14

  • 1Bernareggi A, Rowland M. Physiologic modeling of cyclosporin kinetics in rat and man[J]. J Pharmacokinet Biopharm, 1991, 19 (1):21-50.
  • 2Bjorkman S, Wada D R, Berling B M,et al. Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model[J]. J Pharm Sci, 2001, 90 (9) : 1226-1211.
  • 3Bradshaw Pierce E L, Eckhardt S G, Gustafson D L. A physiologically based pharmacokinetie model of docetaxel disposition: from mouse to man[J].Clin Cancer Res, 2007, 13(9): 27684- 2776.
  • 4Buur J L, Baynes R E, Riviere J E. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model[J]. Regul Toxicol Pharmacol, 2008, 51(3): 324-331.
  • 5Buur J, Baynes R, Smith G, et al. Use of probabilistic modeling wilhin a physiologically based pharmaeokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine[J]. Antimicrob Agents Chemother, 2006, 50(7): 2344-2351.
  • 6Buur J L, Baynes R E, Craigmill A L, et al. Development of a physiologic based pharmacokinetic model for estimating sulfa methazine concentrations in swine and application to prediction of violative residues in edible tissues[J]. Am J Vet Res, 2005, 66 (10): 1686- 1693.
  • 7Buur J L, Baynes R E, Smith G W,et al. A physiologically based pharmacokinetic model linking plasma protein binding interac tions with drug disposition[J].Res Vet Sci, 2009, 86(2):293- 301.
  • 8Clewell H R. The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances[J]. Toxicol Lett, 1995, 79(1-3) : 207-217.
  • 9Edginton A N, Willmann S. Physiology based simulations of a pathological condition: prediction o[ pharmacokinetics in patients with liver cirrhosis[J].Clin Pharmacokinet, 2008, 47(11): 743 -752.
  • 10Haber L T, Maier A, Zhao Q,et al. Applications of mechanistic data in risk assessment: the past, present, and future[J].Toxi col Sci, 2001, 61(1):32-39.

同被引文献36

  • 1姚美村,姜晓飞,陆亚松,乔延江.生理药动学模型及其在中药研究中的应用[J].世界科学技术-中医药现代化,2007,9(3):55-59. 被引量:7
  • 2Jones H M,Gardner I B,Watson K J. Modelling and PBPK simulation in drug discovery[J]. American Association of Pharma-ceutical Scientists, 2009,11(1) : 155-166.
  • 3Knobloch M, Portier C J, Levinonois O L, et al. Antinociceptive effects, metabolism and disposition of ketamine in ponies Under target controlled drug infusion [ J ]. Toxicol Appl Pharmacol, 2006,216(3) : 373-386.
  • 4Law F C P. A physiologically based pharmacokinetic model for predicting the withdrawal period of oxytetracycline in cultured Chinook salmon (Onchorhynchus tshawytscha) [A]. In.. Smith D,Gingerich W H, et al. Xenobiotics in Fish[C]. New York: Kluwer Academic/Plenum Publishers, 1999,105 - 121.
  • 5MacLachlan D J. Physiologically based pharrnacokinetic (PBPK) model for residues of lipophilic pesticides in poultry[J]. Food Additive and Contaminants,2010,27(3) :302-314.
  • 6Michael H D. Microcomputer programs for physiologically-based pharmacokinetic (PB-PK) modeling[J]. Computer Methods and Programs in Biomedicine, 1994,45(3) :213-221.
  • 7Thygesen P, Macheras P, Van Peer A. Physiologically-based PK/ PD modelling of therapeutic maeromolecules[J]. Pharmaceutical Research, 2009,26 (12) : 2543- 2550.
  • 8杨波,黄玲利,刘字,等.喹乙醇及代谢物3-甲基喹喔啉-2-羧酸在猪体内生理药动学模型的建立[C].第九届全国药物和化学异物代谢学术会议论文集,2009.
  • 9杨波,黄玲利,袁宗辉,等.生理药动学模型的软件研究概况[C].第十一届全国数学药理学学术会议,2007.
  • 10蔡劳芹.环丙沙星在大鼠的生理药物动力学模型及其种属间外推[D].广州:华南农业大学,2007.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部